Options traders have been turning deal chatter into quick profits.
Thursday afternoon, trading in animal health company Zoetis was halted on a Wall Street Journal report that the company was approached by Canada-based drugmaker Valeant Pharmaceuticals for a potential takeover. When the stock reopened, shares soared more than 11 percent into the close. And that meant a cool win for one smart trader.
And seemingly right as the news hit, one trader purchased 300 of the June 26 weekly 50-strike calls in Zoetis for 34 cents. Since buying a call option allows one the right to purchase a stock at a set price for a given time, this is a bullish bet that the stock would be above $50.34 by Friday.
"Right after the stock spiked those calls appreciated dramatically," added Nathan, founder of RiskReversal.com. "They were purchased for 34 cents, which is about $10,000 in premium for those 300 calls," and after the halt they were offered at $4.80 or worth about $144,000. That $144,000 represents more than $130,000 of pure profits, meaning the trader made 1,300 percent in just a matter of minutes.
This isn't the first time options traders have made money on takeover talks. Just last week one trader cleaned house on reports of a Martha Stewart deal. In that case, a trader was able to make more than $200,000 in just a matter of minutes.
But Nathan warns that this is not necessarily the smartest strategy for investors. "It seems a bit like a frenzy here. I don't think you want to go out and buy calls for every stock you hear is going to be taken over or rumors floated."
To note, CNBC's David Faber is reporting Friday that Valeant is not going to pursue a deal for Zoetis.
25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256
World Financial Markets - 0700 17 600 Varchev Exchange - 0700 115 44
Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.
Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006
The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.